Ascendis Pharma As Stock Analysis

ASND Stock  USD 169.90  7.30  4.12%   
Ascendis Pharma AS is undervalued with Real Value of 182.68 and Hype Value of 170.44. The main objective of Ascendis Pharma stock analysis is to determine its intrinsic value, which is an estimate of what Ascendis Pharma AS is worth, separate from its market price. There are two main types of Ascendis Pharma's stock analysis: fundamental analysis and technical analysis.
The Ascendis Pharma stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Ascendis Pharma's ongoing operational relationships across important fundamental and technical indicators.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Ascendis Pharma AS. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices.

Ascendis Stock Analysis Notes

About 99.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 6.8. Ascendis Pharma AS had not issued any dividends in recent years. Ascendis Pharma AS, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark. Ascendis Pharma is traded on NASDAQ Exchange in the United States. For more info on Ascendis Pharma AS please contact Jan Mikkelsen at 45 70 22 22 44 or go to https://ascendispharma.com.

Ascendis Pharma AS Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Ascendis Pharma's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Ascendis Pharma AS or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
The company reported the previous year's revenue of 363.64 M. Net Loss for the year was (378.08 M) with profit before overhead, payroll, taxes, and interest of 314.5 M.
Ascendis Pharma AS currently holds about 955.15 M in cash with (306.2 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 17.11.
Ascendis Pharma AS has a frail financial position based on the latest SEC disclosures
Over 99.0% of the company shares are held by institutions such as insurance companies

Ascendis Pharma AS Upcoming and Recent Events

15th of February 2024
Upcoming Quarterly Report
View
25th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
15th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Ascendis Market Capitalization

The company currently falls under 'Large-Cap' category with a current market capitalization of 10.28 B.

Ascendis Profitablity

The company has Profit Margin (PM) of (0.93) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.03) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.03.

Technical Drivers

As of the 20th of July, Ascendis Pharma shows the mean deviation of 1.66, and Risk Adjusted Performance of 0.0509. Ascendis Pharma AS technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Ascendis Pharma AS information ratio, and the relationship between the downside deviation and value at risk to decide if Ascendis Pharma AS is priced correctly, providing market reflects its regular price of 169.9 per share. Given that Ascendis Pharma has jensen alpha of 0.0186, we suggest you to validate Ascendis Pharma AS's prevailing market performance to make sure the company can sustain itself at a future point.

Ascendis Pharma AS Price Movement Analysis

The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Simple Moving Average indicator is calculated by adding the closing price of Ascendis Pharma for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out Ascendis Pharma AS short-term fluctuations and highlight longer-term trends or cycles.

Ascendis Pharma Outstanding Bonds

Ascendis Pharma issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Ascendis Pharma AS uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Ascendis bonds can be classified according to their maturity, which is the date when Ascendis Pharma AS has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Ascendis Pharma Predictive Daily Indicators

Ascendis Pharma intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Ascendis Pharma stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Ascendis Pharma Forecast Models

Ascendis Pharma's time-series forecasting models are one of many Ascendis Pharma's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Ascendis Pharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Ascendis Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Ascendis Pharma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Ascendis shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Ascendis Pharma. By using and applying Ascendis Stock analysis, traders can create a robust methodology for identifying Ascendis entry and exit points for their positions.
Ascendis Pharma AS, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark. Ascendis Pharma is traded on NASDAQ Exchange in the United States.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Ascendis Pharma to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Stock Screener Now

   

Stock Screener

Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
All  Next Launch Module

Complementary Tools for Ascendis Stock analysis

When running Ascendis Pharma's price analysis, check to measure Ascendis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ascendis Pharma is operating at the current time. Most of Ascendis Pharma's value examination focuses on studying past and present price action to predict the probability of Ascendis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ascendis Pharma's price. Additionally, you may evaluate how the addition of Ascendis Pharma to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Equity Valuation
Check real value of public entities based on technical and fundamental data
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios